In a positive step towards supporting the Egyptian patient and an attempt to reduce his financial burdens, Zeta Pharma for Pharmaceutical Industries announced an official reduction in the price of “Empacoza 25 mg” to the public by approximately 40%, after the approval of the Egyptian Drug Authority, in order to facilitate the benefit of the largest possible number of Type 2
